Literature DB >> 16427046

Cell cycle and cell death regulation of neural progenitor cells in the 5-azacytidine (5AzC)-treated developing fetal brain.

Masaki Ueno1, Kei-ichi Katayama, Hirofumi Yamauchi, Hiroyuki Nakayama, Kunio Doi.   

Abstract

In the developing brain, neural progenitor cells are susceptible to many extrinsic stresses, including DNA damage. We treated pregnant rats with 5-azacytidine (5AzC), a DNA demethylating and damaging agent, to investigate the cellular responses of the fetal brain, focusing on the regulation of proliferation and cell death. 5AzC first induced the accumulation of cells in abnormal mitosis, G2-phase accumulation, and then apoptosis of the neural progenitor cells. Most of the apoptotic cells were in G1 phase. Cell cycle transition studies suggested that G2/M progression was blocked, after which the cells moved to G1 phase or underwent apoptosis. p53, a key factor for response to DNA damage, and some of its target genes showed increased expression in Western blot and DNA microarray analyses. In 5AzC-treated fetal brains of p53-deficient mice, apoptosis did not occur, although G2/M accumulation was induced. These results suggest that, in the developing brain, apoptosis is p53-dependent but that another mechanism governs the G2/M checkpoint. The G2/M regulator, Cdc2, was activated by dephosphorylation through G2/M accumulation, suggesting accelerated entry into mitosis leading to accumulation of cells showing abnormal mitosis. Furthermore, some cells may have died due to mitotic catastrophe. Throughout brain development, various cell cycle and cell death regulation mechanisms provide neural progenitor cells with options for defense from DNA damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16427046     DOI: 10.1016/j.expneurol.2005.11.024

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

Review 1.  Dad's Snoring May Have Left Molecular Scars in Your DNA: the Emerging Role of Epigenetics in Sleep Disorders.

Authors:  Daniela Morales-Lara; Clelia De-la-Peña; Eric Murillo-Rodríguez
Journal:  Mol Neurobiol       Date:  2017-02-02       Impact factor: 5.590

2.  Determinants of orofacial clefting I: Effects of 5-Aza-2'-deoxycytidine on cellular processes and gene expression during development of the first branchial arch.

Authors:  Partha Mukhopadhyay; Ratnam S Seelan; Francine Rezzoug; Dennis R Warner; Irina A Smolenkova; Guy Brock; M Michele Pisano; Robert M Greene
Journal:  Reprod Toxicol       Date:  2016-11-30       Impact factor: 3.143

3.  Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobin.

Authors:  Rodwell Mabaera; Michael R Greene; Christine A Richardson; Sarah J Conine; Courtney D Kozul; Christopher H Lowrey
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

Review 4.  Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways.

Authors:  Kunio Doi; Koji Uetsuka
Journal:  Int J Mol Sci       Date:  2011-08-15       Impact factor: 5.923

5.  RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.

Authors:  Jun Muto; Takao Imai; Daisuke Ogawa; Yoshinori Nishimoto; Yohei Okada; Yo Mabuchi; Takeshi Kawase; Akio Iwanami; Paul S Mischel; Hideyuki Saya; Kazunari Yoshida; Yumi Matsuzaki; Hideyuki Okano
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

6.  Distribution and sequence of pyknotic cells in rat fetuses exposed to busulfan.

Authors:  Toko Ohira; Ryo Ando; Rie Andoh; Tomomi Nakazawa; Kaori Nishihara; Satoshi Yamamoto; Norihiko Nakamura; Kazutoshi Tamura
Journal:  J Toxicol Pathol       Date:  2009-10-15       Impact factor: 1.628

7.  T-2 toxin-induced toxicity in pregnant mice and rats.

Authors:  Kunio Doi; Noriaki Ishigami; Shinya Sehata
Journal:  Int J Mol Sci       Date:  2008-11-05       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.